National Observatory of Mycoplasma Infections in Children Under 18 Ages in France
NCT ID: NCT06260371
Last Updated: 2024-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
3000 participants
OBSERVATIONAL
2023-09-01
2030-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Clinical data from children with mycoplasma infections will be collected to characterise this infection and facilitate hospital management.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incidence of MIS-C and Other Complications Following SARS-CoV-2 Infection
NCT05186597
Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children
NCT04318431
Severe Group A Streptococcus Infections in Paris, France, 2018-2023
NCT06297122
Epidemiological, Clinical and Biological Caracteristics of Patients Presenting With Invasive Meningococcal Disease
NCT05981599
Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France
NCT04336761
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
These following data will be collected: signs or symptoms associated with this infection, clinical complications, biological and microbiological tests done during hospitalisation, treatment used during hospitalization, results of thoracic x-ray and lung ultrasound.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Documented mycoplasma infection (positive multiplex PCR and/or positive serology)
Exclusion Criteria
1 Day
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Groupe de Pathologies Infectieuses Pédiatriques (GPIP)
OTHER
Association Clinique Thérapeutique Infantile du val de Marne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Corinne Levy
Role: STUDY_DIRECTOR
Association Clinique Thérapeutique Infantile du val de Marne
Anais Chosidow
Role: PRINCIPAL_INVESTIGATOR
Hôpital Intercommunal de Villeneuve-Saint-Georges
Emilie Pauquet
Role: PRINCIPAL_INVESTIGATOR
Hôpital des Enfants, CHU de Bordeaux
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ACTIV
Créteil, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ORIGAMI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.